French Govt Plans To Boost Access To Innovation & Increase Use Of Generics & Biosimilars
Executive Summary
The French government’s health strategy for 2018-2022 includes a range of measures to increase patient access to new medicines, raise the level of generic and biosimilar prescribing, and cut down on the use of antibiotics.
You may also be interested in...
French Govt Must Act To Stop ‘Inexorable Decline’ Of Pharmaceutical Industry
The president of France’s industry association Leem says the authorities need to look at new ways of handling the health technology evaluation and pricing of innovative drugs, and to implement more predictable, long-term health policies, if the country is to reverse the “inexorable decline” of the pharmaceutical sector.
French Govt Must Act To Stop ‘Inexorable Decline’ Of Pharmaceutical Industry
The president of France’s industry association Leem says the authorities need to look at new ways of handling the health technology evaluation and pricing of innovative drugs, and to implement more predictable, long-term health policies, if the country is to reverse the “inexorable decline” of the pharmaceutical sector.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.